Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral route
|
| gptkbp:approvalYear |
1991
|
| gptkbp:ATCCode |
J05AF02
|
| gptkbp:CASNumber |
69655-05-6
|
| gptkbp:contraindication |
history of pancreatitis
hypersensitivity to didanosine |
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:eliminationHalfLife |
1.5 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:form |
gptkb:tablet
oral solution |
| gptkbp:genericName |
gptkb:didanosine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Videx
|
| gptkbp:KEGGID |
D00298
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:MedlinePlusID |
a692007
|
| gptkbp:MeSH_ID |
D017964
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:PubChem_CID |
CHEMBL1425
DB00900 135398513 4444441 |
| gptkbp:sideEffect |
nausea
diarrhea pancreatitis peripheral neuropathy lactic acidosis |
| gptkbp:UNII |
X4X229T896
|
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:didanosine
|
| gptkbp:bfsLayer |
6
|